Summary
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests for Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, isothermal reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
History
Meridian Bioscience, Inc. was founded in 1976, and has since grown to become an international life science company with a portfolio of diagnostic test kits, purified reagents and related products and biopharmaceutical enabling technologies, which it sells in some 160 countries. The company has three main operating divisions: Life Science, Diagnostics and Virology.
Mission
Meridian is dedicated to improving Blood and other Human Biofluids testing through innovation, to improving the health and well-being of people around the world, through quality and excellence in our products and services.
Vision
Meridian will focus on developing and delivering superior products and services to customers around the world, with the ultimate goal of providing an unrivalled experience to users of our products.
Key Team
Mr. Jeff Pinkston (Director of Corp. Fin.)
Mr. Andrew S. Kitzmiller (Exec. VP & CFO)
Ms. Julie Smith (Sr. VP, Controller & Principal Accounting Officer)
Ms. Melissa J. McCarey (VP of Global HR)
Mr. Charles Wood (VP of Corp. Strategy, Bus. Devel. & Investor Relations)
Ms. Susan D. Rolih (Consultant)
Mr. Emerson C. Moser (Sr. VP & Gen. Counsel)
Recognition and Awards
Meridian Bioscience, Inc. is the recipient of several awards including the 2020 Baylor College of Medicine Award and the 2018 Wall Street Journal Innovation Award. The company also received an Honorable Mention in the 2018 Global Life Sciences Awards and was named one of Fierce Biotech's Top 10 Innovators in 2018.
References
